Compositions and methods for the treatment of meibomian gland dysfunction
AssigneeAzura Ophthalmics Ltd.
InventorsYair Alster, Omer Rafaeli, K. Angela MacFarlane, Cary Reich, Shimon Amselem, Doron Friedman
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from meibomian gland dysfunction.
Claims14
A method for treating meibomian gland dysfunction in a patient in need thereof, comprising topically administering to the patient a composition that reaches the eyelid margin of the patient, wherein the composition comprises a therapeutically-effective amount of benzoyl peroxide in an ophthalmically-acceptable carrier and wherein the meibomian gland dysfunction is characterized by keratinized obstruction.
Dependencies are inferred from the claim text.